A group based on complementary expertise with multidisciplinary know-how

A range of integrated biotechnology solutions

News

QVQ joins the Biotech Investissement Group

Date of publication : 12/10/2018

Dear Customers and Partners

We are pleased to announce that QVQ, a company based in Utrecht (The Netherlands), is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (Biotech Investissement Group – www.mabexperts.com).

QVQ has strong expertise in the development and production of single domain antibodies derived from llamas, which are referred to as VHHs. VHHs have unique biochemical properties due to their small size and high stability which make them very useful for tumour targeting particularly in imaging technologies and companion diagnostics. QVQ offers multiple services related to development, reformatting and optimization of VHHs with respect to stability, production levels and humanization. Besides contract research and services, QVQ has developed a growing portfolio of proprietary detection/imaging VHHs directed against targets in disease related with oncology, age disease and infectious diseases.

By joining the Biotech Investissement group, QVQ will complement the high level of expertise already present within the group, to develop and market new high-quality diagnostic assays and imaging products.

Please do not hesitate to get in touch if you require information about the QVQ products and services.

Yours faithfully

 Philippe Dulieu, CEO

Contact:

Phone +33(0)3 81 53 88 37 – Mail : info@mabexperts.com

  • CAM FAMILY
    The CAM family: A new target for monitoring or treating cancers?
    Date of publication : 21/05/2019

    The cell adhesion molecules (CAMs) family includes more than 50 proteins with four main groups: immunoglobulin (Ig)-like CAMs, cadherins, selectins, and integrins.

    Diaclone has been interested for...

    Read more
  • FAST ELISA
    Discover and test the RD-BIOTECH fastELISA Kits:
    Date of publication : 21/05/2019

    Discover and test the RD-BIOTECH fastELISA Kits: The quickest ELISA Kits on the market!

    Easy one-step process – Results in less than 30 minutes – Coloured pipetting tracking –...

    Read more
  • PSL
    PSL Alliance
    Date of publication : 18/05/2019

    Diaclone is a core member of the PSL Alliance, a network of biotech companies gathered by UK-based company Pivotal Scientific...

    Read more
  • EuSARC 2019
    EuSARC 2019
    Date of publication : 07/05/2019

    Diaclone  is pleased to be sponsor of the EuSARC congress, taking place on May 30th-June 1st in Benediktbeuern, Germany. Don't hesitate to contact our Area sales manager, Norbert Gregor, in...

    Read more
  • AIS LOGO
    7th Antibody Industrial Symposium 2019
    Date of publication : 23/04/2019



    Diaclone and the mAbexperts group will be present at the 7th Antibody Industrial Symposium 2019 (AIS 2019)  “Harnessing the immune system with therapeutic antibodies” jointly...

    Read more
  • IL-17
    DIACLONE Assays for the Human IL-17 Family
    Date of publication : 23/04/2019

    DIACLONE has developed one of the largest ranges of ELISA and ELISpot kits available for the detection of Human IL-17A, IL-17F and IL-17A/F:




    Human IL-17A ELISpot...

    Read more
  • Prod cell
    NEW! RD-Biotech supplier of murine monoclonal antibody D1-25, for the quantification of rabies virus by ELISA.
    Date of publication : 08/04/2019

    Signature of a license agreement with Institut Pasteur - France: RD-Biotech becomes the supplier of the clone D1-25 (anti-rabies virus monoclonal antibody)


    PRODUCT SPECIFICATIONS:
    - Clone:...

    Read more
  • QVQ joins the Biotech Investissement Group
    Date of publication : 12/10/2018

    Dear Customers and Partners

    We are pleased to announce that QVQ, a company based in Utrecht (The Netherlands), is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (Biotech...

    Read more
  • Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
    Date of publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Read more